TP53 mutations are observedin up to 30% of primary glioblastomas, and the TP53 mutation status is closely linked to the disease progression andsurvival rates of the patients with glioblastoma who receive radiotherapyand chemotherapy.14 The gene discussed is TP53; the disease is glioblastoma.